4,5,6,7-tetrabromo-2-azabenzimidazole has been researched along with Glioma in 1 studies
4,5,6,7-tetrabromobenzotriazole: a CK2 kinase inhibitor
Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dixit, D | 1 |
| Ahmad, F | 1 |
| Ghildiyal, R | 1 |
| Joshi, SD | 1 |
| Sen, E | 1 |
1 other study available for 4,5,6,7-tetrabromo-2-azabenzimidazole and Glioma
| Article | Year |
|---|---|
CK2 inhibition induced PDK4-AMPK axis regulates metabolic adaptation and survival responses in glioma.
Topics: Adenosine Triphosphate; AMP-Activated Protein Kinases; Animals; Brain Neoplasms; Casein Kinase II; C | 2016 |